Metastatic Gastric Cancers Completed Phase 2 Trials for Sorafenib (DB00398)

Also known as: Metastatic Gastric Cancer / Gastric cancer stage IV NOS / Gastric cancer stage IV / Malignant neoplasm of stomach stage IV NOS / Gastric malignancy stage IV NOS / Stomach cancer stage IV NOS

IndicationStatusPhase
DBCOND0063580 (Metastatic Gastric Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00253370Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction CancerTreatment